Primary prevention of ovarian cancer by salpingectomy: that's one small step for a surgeon, one giant leap for patients Ingo B. RunnebaumAngela Kather Guest Editorial Open access 29 March 2023 Pages: 6799 - 6801
Discovery of potential biomarkers for lung cancer classification based on human proteome microarrays using Stochastic Gradient Boosting approach Ning YaoJianbo PanYazhou Wu Research 18 February 2023 Pages: 6803 - 6812
A survival prediction model via interpretable machine learning for patients with oropharyngeal cancer following radiotherapy Xiaoying PanTianhao FengX. Sharon Qi Research 18 February 2023 Pages: 6813 - 6825
GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females Yuxuan SongCaipeng QinTao Xu Research 19 February 2023 Pages: 6827 - 6840
Bleeding-related re-exploration following pulmonary resection: a report of a single-center experience Shanbo ZhengTing YeHaiquan Chen Research 20 February 2023 Pages: 6841 - 6848
The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study Aykut DemirkıranFahriye KılınçMehmet Artaç Research 20 February 2023 Pages: 6849 - 6856
Risk mapping of lung cancer: a comprehensive appraisal of published meta-analyses incorporating Mendelian randomization studies Caichen LiJianfu LiWenhua Liang Research 21 February 2023 Pages: 6857 - 6873
ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study Sanna IivanainenRavi RavichandraJussi P. Koivunen Research Open access 21 February 2023 Pages: 6875 - 6882
Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma Ya FengTianjiao LiChenggang Li Research 22 February 2023 Pages: 6883 - 6899
Molecular phenotypic linkage between N6-methyladenosine methylation and tumor immune microenvironment in hepatocellular carcinoma Feng ZhangJunming BiShuijiao Guo Research 24 February 2023 Pages: 6901 - 6916
Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease Alyne Condurú dos Santos CunhaAdrian Georg SimonAlexander Quaas Research Open access 24 February 2023 Pages: 6917 - 6929
Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer Yuanqiao HeJiaqi MeiXiongbing Lu Research 25 February 2023 Pages: 6931 - 6941
Extracapsular extension of transitional zone prostate cancer miss-detected by multiparametric magnetic resonance imaging Xin ChenWei LiXuedong Wei Research 27 February 2023 Pages: 6943 - 6952
Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany I. B. RunnebaumA. KatherJ. Sehouli Research Open access 27 February 2023 Pages: 6953 - 6966
Integrative analyses of bulk microarray data to discover genes, pathways, and immune infiltration characteristics associated with targeting of Ewing sarcoma Binjie CaoHaijian SunHaibo Sun Research Open access 27 February 2023 Pages: 6967 - 6977
Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective–prospective cohort multicentre study Alvydas CesasVincas UrbonasIgnas Gaidamavicius Research Open access 27 February 2023 Pages: 6979 - 6988
Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors Vivien TopfYuri KheifetzMaren Knödler Research Open access 28 February 2023 Pages: 6989 - 6998
The relationship of airflow limitation with lung squamous cell carcinoma: evidence from mendelian randomization analysis Qing ZhangGuannan CaiYing Chen Research 28 February 2023 Pages: 6999 - 7006
Whole body irradiation with intensity-modulated helical tomotherapy prior to haematopoietic stem cell transplantation: analysis of organs at risk by dose and its effect on blood kinetics Mümtaz KöksalJonathan BaumertLeonard C. Schmeel Research Open access 01 March 2023 Pages: 7007 - 7015
Based on ARASENS trial: efficacy and safety of darolutamide as an emerging option of endocrinotherapy for metastatic hormone-sensitive prostate cancer—an updated systematic review and network meta-analysis Maoyang DouHao LiangBenkang Shi Research 01 March 2023 Pages: 7017 - 7027
The investigation of volatile organic compounds in diagnosing (early) esophageal squamous cell carcinoma and gastric adenocarcinoma Hang YangChengfang XiangBing Hu Research 02 March 2023 Pages: 7029 - 7041
Adverse outcomes and health-ecological influencing factors of preoperative frailty among elderly patients with gastric cancer Lingyu DingXueyi MiaoQin Xu Research 02 March 2023 Pages: 7043 - 7051
Palmitic acid combined with γ-interferon inhibits gastric cancer progression by modulating tumor-associated macrophages’ polarization via the TLR4 pathway Yan-Yan ZhangJian LiLi Feng Research 02 March 2023 Pages: 7053 - 7067
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis Jaya NigamHasan Raza KazmiAbhijit Chandra Research 04 March 2023 Pages: 7069 - 7078
Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis Klaus-Peter DieckmannCansu DumlupinarGazanfer Belge Research Open access 04 March 2023 Pages: 7079 - 7090
Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database Peter BorchmannJan-Michel HegerBarbara Werner Research 05 March 2023 Pages: 7091 - 7101
The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia Anna DeręgowskaMonika PępekTomasz Stokłosa Research Open access 05 March 2023 Pages: 7103 - 7112
TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer Irene StrasslArmin WindhagerAnsgar Weltermann Research Open access 06 March 2023 Pages: 7113 - 7123
The significance of spread through air spaces in the prognostic assessment model of stage I lung adenocarcinoma and the exploration of its invasion mechanism YangYang NiuXinHao HanXiaoMei Li Research 07 March 2023 Pages: 7125 - 7138
PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma Yuting WenYi WangChan Hui Research 08 March 2023 Pages: 7139 - 7153
Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients L. ProppeT. JagomastL. C. Hanker Research Open access 08 March 2023 Pages: 7155 - 7164
Standard deviation of CT radiomic features among malignancies in each individual: prognostic ability in lung cancer patients Si HongweiHao XinzhongLi Sijin Research 08 March 2023 Pages: 7165 - 7173
A clinically applicable prediction model for the risk of in-hospital mortality in solid cancer patients admitted to intensive care units with sepsis ChengYong MaGuoRui SunShuo Yang Research 08 March 2023 Pages: 7175 - 7185
Differential diagnosis of lymphoma with 18F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy Jia ChenDong XuJian-Xin Song Research Open access 08 March 2023 Pages: 7187 - 7196
Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany Andreas SchmidtChristiane BernhardtFlorian H. Heidel Research Open access 08 March 2023 Pages: 7197 - 7206
Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy Milad MoloudizargariShirin HekmatiradMohammad Hossein Asghari Research 08 March 2023 Pages: 7207 - 7216
Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment Kenneth K. W. ToKa M. CheungWilliam C. S. Cho Research 11 March 2023 Pages: 7217 - 7234
TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer Yaoqing LiChuchu XuGuolin Zhang Research 11 March 2023 Pages: 7235 - 7246
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer Nanwei XuJinge ZhaoHao Zeng Research 13 March 2023 Pages: 7247 - 7258
The evaluation of tumor microenvironment infiltration and the identification of angiogenesis-related subgroups in skin cutaneous melanoma Junpeng LiHangjun RenXiaolu Li Research 13 March 2023 Pages: 7259 - 7273
Low diffusion capacity predicts poor prognosis in extensive stage small cell lung cancer: a single-center analysis of 10 years Jee Seon KimEun Ji KimJune Hong Ahn Research Open access 13 March 2023 Pages: 7275 - 7283
New insights into breast microcalcification for poor prognosis: NACT cohort and bone metastasis evaluation cohort Yangling HuLijuan MaoXiaoling Zhang Research 14 March 2023 Pages: 7285 - 7297
Female breast cancer subtypes in the Romagna Unit of the Emilia-Romagna cancer registry, and estimated incident cases by subtypes and age in Italy in 2020 Emanuele CrocettiAlessandra RavaioliFabio Falcini Research Open access 15 March 2023 Pages: 7299 - 7304
Long non-coding RNA ENST00000503625 is a potential prognostic biomarker and metastasis suppressor gene in prostate cancer Yaoming LiZiyu FangLuofu Wang Research 15 March 2023 Pages: 7305 - 7317
Intercontinental comparison of women with breast cancer treated by oncologists in Europe, Asia, and Latin America: a retrospective study of 99,571 patients Arturas KadysNiklas GremkeMatthias Kalder Research Open access 15 March 2023 Pages: 7319 - 7326
FTO-mediated m6A modification promotes malignant transformation of gastric mucosal epithelial cells in chronic Cag A+ Helicobacter pylori infection Sha ChengHuan LiCanxia Xu Research Open access 15 March 2023 Pages: 7327 - 7340
Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility study Jingjing SunFeng LiLei Shi Research 16 March 2023 Pages: 7341 - 7353
The effect of gastrointestinal microbiome supplementation on immune checkpoint inhibitor immunotherapy: a systematic review Anjali BhattAlyson HaslamVinay Prasad Research Open access 16 March 2023 Pages: 7355 - 7362
Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer Huan QinHaiyan HuQiang Li Research 18 March 2023 Pages: 7363 - 7378
Machine learning-based immune prognostic model and ceRNA network construction for lung adenocarcinoma Xiaoqian HeYing SuWenjia Guo Research 20 March 2023 Pages: 7379 - 7392
